RecruitingPhase 3NCT07584525
Dexamethasone in Tick-borne Encephalitis
Treatment With Dexamethasone in Patients With Tick-borne Encephalitis: Randomized Clinical Trial
Sponsor
University Medical Centre Ljubljana
Enrollment
200 participants
Start Date
May 3, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Dexametasone and a drug called Saline (0.9% NaCl) for people with tick borne encephalitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexametasone
dexamethasone 4 mg tid
DRUGSaline (0.9% NaCl)
20 ml saline
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07584525